Adjuvant Endocrine Therapy and Risk of Contralateral Breast Cancer among U.S. Women with Breast Cancer

IMPORTANCE: Within ten years after breast cancer diagnosis, 5% of patients develop contralateral primary breast cancer (CBC). Randomized trials have found that tamoxifen and aromatase inhibitors (AIs) reduce CBC risk. However, little is known about the magnitude and duration of protective effects wi...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:JAMA Oncol
Main Authors: Gierach, Gretchen L., Curtis, Rochelle E., Pfeiffer, Ruth M., Mullooly, Maeve, Ntowe, Estelle A., Hoover, Robert N., Nyante, Sarah J., Feigelson, Heather Spencer, Glass, Andrew G., de Gonzalez, Amy Berrington
Format: Artigo
Sprog:Inglês
Udgivet: 2016
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5757540/
https://ncbi.nlm.nih.gov/pubmed/27711920
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2016.3340
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker